Evidence map›Paper›PMID 21907265›Full record

ArticleNeuroscience2011

DJ-1 knock-down impairs astrocyte mitochondrial function.

N J Larsen, G Ambrosi, S J Mullett, S B Berman, D A Hinkle

Abstract read
In one paragraph

Article in Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. PGC-1s in the Spotlight with Parkinson's Disease.International journal of molecular sciences · 2021
    Review
  13. Review
  14. Review
  15. Review
  16. The new role of FExperimental neurology · 2020
    Review
  17. Article
  18. Review
  19. Dietary Antioxidants and Parkinson's Disease.Antioxidants (Basel, Switzerland) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

N J LarsenDepartment of Neurology, Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
G Ambrosi
S J Mullett
S B Berman
D A Hinkle
Institute for Neurodegenerative Disorders · USIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Pittsburgh · US

Funding

DJ-1 in Astrocyte-Mediated Neuroprotection Against Complex I InhibitorsR01ES020327 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GREENAMYRE, J TIMOTHY · 2011 to 2015
$1.7M
The Potential Role of DJ-1 in Astrocyte-Mediated NeuroprotectionK08NS055736 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HINKLE, DAVID A · 2007 to 2011
$844k
NIEHS NIH HHS R01 ES020327NINDS NIH HHS K08 NS055736
6 · The paper itself

Abstract

Mitochondrial dysfunction has long been implicated in the pathogenesis of Parkinson's disease (PD). PD brain tissues show evidence for mitochondrial respiratory chain Complex I deficiency. Pharmacological inhibitors of Complex I, such as rotenone, cause experimental parkinsonism. The cytoprotective protein DJ-1, whose deletion is sufficient to cause genetic PD, is also known to have mitochondria-stabilizing properties. We have previously shown that DJ-1 is over-expressed in PD astrocytes, and that DJ-1 deficiency impairs the capacity of astrocytes to protect co-cultured neurons against rotenone. Since DJ-1 modulated, astrocyte-mediated neuroprotection against rotenone may depend upon proper astrocytic mitochondrial functioning, we hypothesized that DJ-1 deficiency would impair astrocyte mitochondrial motility, fission/fusion dynamics, membrane potential maintenance, and respiration, both at baseline and as an enhancement of rotenone-induced mitochondrial dysfunction. In astrocyte-enriched cultures, we observed that DJ-1 knock-down reduced mitochondrial motility primarily in the cellular processes of both untreated and rotenone treated cells. In these same cultures, DJ-1 knock-down did not appreciably affect mitochondrial fission, fusion, or respiration, but did enhance rotenone-induced reductions in the mitochondrial membrane potential. In neuron-astrocyte co-cultures, astrocytic DJ-1 knock-down reduced astrocyte process mitochondrial motility in untreated cells, but this effect was not maintained in the presence of rotenone. In the same co-cultures, astrocytic DJ-1 knock-down significantly reduced mitochondrial fusion in the astrocyte cell bodies, but not the processes, under the same conditions of rotenone treatment in which DJ-1 deficiency is known to impair astrocyte-mediated neuroprotection. Our studies therefore demonstrated the following new findings: (i) DJ-1 deficiency can impair astrocyte mitochondrial physiology at multiple levels, (ii) astrocyte mitochondrial dynamics vary with sub-cellular region, and (iii) the physical presence of neurons can affect astrocyte mitochondrial behavior.

Indexed as

AnimalsAstrocytesCell Physiological PhenomenaCells, CulturedCoculture TechniquesCytoprotectionGene Knockdown TechniquesGlycolysisMembrane Potential, MitochondrialMiceMice, Inbred ICRMitochondriaMolecular ImagingNeuronsOncogene ProteinsOxygen ConsumptionOncogene ProteinsPARK7 protein, mousePeroxiredoxinsProtein Deglycase DJ-1Rotenone

Identifiers

PMID21907265
PMCPMC3490195
OpenAlexW2048830349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.